{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:02:29Z","timestamp":1777723349607,"version":"3.51.4"},"reference-count":94,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Chimeric antigen receptor (CAR)-T-cell therapy has sparked a wave of optimism in hematological malignancies, reflected by the successful results of early clinical trials involving patients with pre-B-cell acute lymphoblastic leukemia, B-cell lymphomas and multiple myeloma. CAR-T-cell therapy is considered to be a novel immunotherapy treatment that has the potential for curing certain hematological cancers. However, as use of CAR-T-cell therapy has grown, new challenges have surfaced. These challenges include the process of manufacturing the CAR-T cells, the mechanisms of resistance that underlie disease relapse, adverse effects and cost. This review describes the published results of clinical trials and expected developments to overcome CAR-T resistance.<\/jats:p>","DOI":"10.1136\/jim-2020-001290","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T13:49:28Z","timestamp":1584798568000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["Car-T Treatment for Hematological Malignancies"],"prefix":"10.1177","volume":"68","clinical-trial-number":[{"clinical-trial-number":"nct03464916","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03672318","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-7534","authenticated-orcid":false,"given":"Shebli","family":"Atrash","sequence":"first","affiliation":[{"name":"Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulsum","family":"Bano","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al-Ola","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"bibr1-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"bibr2-jim-2020-001290","first-page":"277","volume":"9","author":"Park JH","year":"2010","journal-title":"Discov Med"},{"key":"bibr3-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.720"},{"key":"bibr4-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.83"},{"key":"bibr5-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2422"},{"key":"bibr6-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2017.1304354"},{"key":"bibr7-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504542"},{"key":"bibr8-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031330"},{"key":"bibr9-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.12.4067-4074.2001"},{"key":"bibr10-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2043"},{"key":"bibr11-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4463"},{"key":"bibr12-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000379"},{"key":"bibr13-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.08.019"},{"key":"bibr14-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-535088"},{"key":"bibr15-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09241.x"},{"key":"bibr16-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"bibr17-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.205"},{"key":"bibr18-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.04.024"},{"key":"bibr19-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x"},{"key":"bibr20-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocit.2014.11.001"},{"key":"bibr21-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86000"},{"key":"bibr22-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2510"},{"key":"bibr23-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7746"},{"key":"bibr24-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02361"},{"key":"bibr25-jim-2020-001290","volume":"13","author":"Spear P","year":"2013","journal-title":"Cancer Immun"},{"key":"bibr26-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729"},{"key":"bibr27-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9"},{"key":"bibr28-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141"},{"key":"bibr29-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"bibr30-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0040"},{"key":"bibr31-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"bibr32-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-131799"},{"key":"bibr33-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005930"},{"key":"bibr34-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0028"},{"key":"bibr35-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002842"},{"key":"bibr36-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384388"},{"key":"bibr37-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S150524"},{"key":"bibr38-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.1547.1547"},{"key":"bibr39-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0698"},{"key":"bibr40-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_238691"},{"key":"bibr41-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-881722"},{"key":"bibr42-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2595"},{"key":"bibr43-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0184-6"},{"key":"bibr44-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309"},{"key":"bibr45-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862"},{"key":"bibr46-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.016"},{"key":"bibr47-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3181eacbd8"},{"key":"bibr48-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"bibr49-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-117729"},{"key":"bibr50-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0442"},{"key":"bibr51-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25235"},{"key":"bibr52-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0146-z"},{"key":"bibr53-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1020"},{"key":"bibr54-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood. V64.3.701.701"},{"key":"bibr55-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1054-1"},{"key":"bibr56-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.302"},{"key":"bibr57-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0231"},{"key":"bibr58-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-265884"},{"key":"bibr59-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215134"},{"key":"bibr60-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"bibr61-jim-2020-001290","unstructured":"Fda approves tisagenlecleucel for B-cell all and tocilizumab for cytokine release syndrome. Available: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-tisagenlecleucel-b-cell-all-and-tocilizumab-cytokine-release-syndrome"},{"key":"bibr62-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"bibr63-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-577189"},{"key":"bibr64-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"bibr65-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"bibr66-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"bibr67-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408773"},{"key":"bibr68-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.213"},{"key":"bibr69-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.9593"},{"key":"bibr70-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"bibr71-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"bibr72-jim-2020-001290","unstructured":"U.S. Food & Drug administration. KYMRIAH (tisagenlecleucel). Available: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/kymriah-tisagenlecleucel"},{"key":"bibr73-jim-2020-001290","unstructured":"U.S. Food & Drug administration. YESCARTA. Available: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/yescarta-axicabtagene-ciloleucel"},{"key":"bibr74-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7505"},{"key":"bibr75-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.1"},{"key":"bibr76-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"bibr77-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509981"},{"key":"bibr78-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-03-901090"},{"key":"bibr79-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2019.04.002"},{"key":"bibr80-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1446"},{"key":"bibr81-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood. V124.21.330.330"},{"key":"bibr82-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01580"},{"key":"bibr83-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127603"},{"key":"bibr84-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood. V124.21.1982.1982"},{"key":"bibr85-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01613"},{"key":"bibr86-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224204"},{"key":"bibr87-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0119-y"},{"key":"bibr88-jim-2020-001290","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE). version 5.0. Available: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf [Accessed 29 Dec 2019]."},{"key":"bibr89-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0571-y"},{"key":"bibr90-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0627-z"},{"key":"bibr91-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"bibr92-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"bibr93-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"bibr94-jim-2020-001290","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-121731"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2020-001290","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1136\/jim-2020-001290","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2020-001290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:37:03Z","timestamp":1777459023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1136\/jim-2020-001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/jim-2020-001290"],"URL":"https:\/\/doi.org\/10.1136\/jim-2020-001290","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}